Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Bendamustine, Gemcytabine, Dexamethasone (BGD) Salvage Chemotherapy With autoSCT Consolidation in Advanced Classical HL Patients Not Responding to ABVD - Multicentre Phase II Clinical Study - PLRG-HL1

NCT03615664 is registered in ClinicalTrials.gov with Polish Lymphoma Research Group as lead sponsor.

NCT NCT03615664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03615664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Bendamustine, Gemcytabine, Dexamethasone (BGD) Salvage Chemotherapy With autoSCT Consolidation in Advanced Classical HL Patients Not Responding to ABVD - Multicentre Phase II Clinical Study - PLRG-HL1
Lead sponsor
Polish Lymphoma Research Group
Phase
Phase 2
Overall status
Completed
Start date
November 6, 2017
Completion date
December 31, 2024
Enrollment
115 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin's lymphoma